Cialis y Tadalafil Genérico: Tratamiento Efectivo para los Problemas de Erección en NYC

Cialis > cialis tadalafil 20mg


The population was 86%

Parameter Value Notes
Absorption Time 30-120 minutes Peak plasma levels at ~2 hours
Duration of Effect Up to 36 hours Long-lasting effect
Bioavailability 40% Percentage of drug reaching circulation
Metabolism Liver (CYP3A4 enzyme) Mainly processed in the liver

White, 3% Black, 0.4% Hispanic,

  • Cialis Tadalafil 20mg is approved by the FDA.
  • It helps improve confidence in intimate moments.
  • Lifestyle changes can enhance medication effectiveness.
  • Exercise regularly and maintain a healthy diet.
  • Discuss any concerns with your healthcare provider.

and 10% of other ethnicities,

Storage Condition Details
Temperature Store below 30°C (86°F)
Light Exposure Keep in a cool, dry place away from light
Humidity Avoid high humidity environments
Keep Out of Reach of Children Safety precaution

and included patients with ED

Lo Que Necesita Saber:

The results demonstrated a difference between the placebo group and the CIALIS group at each of the pre-specified timepoints. At the 24-hour timepoint, (more specifically, 22 to 26 hours), 53/144 (37%) patients reported at least 1 successful intercourse in the placebo group versus 84/138 (61%) in the CIALIS 20-mg group. At the 36-hour timepoint (more specifically, 33 to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the CIALIS 20-mg group.In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, CIALIS 10, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 and 36 hours post-dosing). Patients were encouraged to make 4 separate attempts at their assigned dose and assigned timepoint. In this study, the results demonstrated a statistically significant difference between the placebo group and the CIALIS groups at each of the pre-specified timepoints.

Alternatives for erectile dysfunction (ED)

At the 24-hour timepoint, the mean, per patient percentage of attempts resulting in successful intercourse were 42, 56, and 67% for the placebo, CIALIS 10-, and 20-mg groups, respectively. At the 36-hour timepoint, the mean, per-patient percentage of attempts resulting in successful intercourse were 33, 56, and 62% for placebo, CIALIS 10-, and 20-mg groups, respectively.14.2 CIALIS for Once Daily UseThe efficacy and safety of CIALIS for once daily use in the treatment of erectile dysfunction has been evaluated in 2 clinical trials of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853 patients. CIALIS, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 2 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12- and 24-weeks duration, respectively. One of these studies was conducted in the United States and one was conducted in centers outside the US. An additional efficacy and safety study was performed in ED patients with diabetes mellitus. of various severities, etiologies (organic,

Product Dosage Quantity + Bonus Price
Cialis Original20mg64 + 4 Pills274.18€ 261.12€
Cialis Professional40mg20 Pills110.24€ 104.99€
Cialis Generic40mg360 + 10 Pills477.87€ 455.11€
Cialis Black80mg30 + 2 Pills89.11€ 84.87€
Cialis Generic5mg120 + 6 Pills132.92€ 126.59€
Cialis Generic2.5mg60 + 4 Pills83.43€ 79.46€
Cialis Professional20mg270 + 6 Pills623.07€ 593.40€
Cialis Generic2.5mg360 + 10 Pills260.03€ 247.65€
Cialis Generic20mg60 + 6 Pills117.76€ 112.15€
Cialis Black80mg20 Pills71.83€ 68.41€
Cialis Generic10mg60 + 6 Pills105.81€ 100.77€
Cialis Original20mg14 + 2 Pills95.75€ 91.19€

psychogenic, mixed), and with multiple

6.2 Postmarketing Experience

14 CLINICAL STUDIES 14.1 CIALIS for Use as NeededThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4000 patients. CIALIS, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).CIALIS was studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration. Two of these studies were conducted in the United States and 5 were conducted in centers outside the US. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, CIALIS was taken as needed, at doses ranging from 2.5 to 20 mg, up to once per day. Patients were free to choose the time interval between dose administration and the time of sexual attempts.

Alternatives for benign prostatic hyperplasia (BPH)

Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of CIALIS on erectile function. The 3 primary outcome measures were the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) and Questions 2 and 3 from Sexual Encounter Profile (SEP). The IIEF is a 4-week recall questionnaire that was administered at the end of a treatment-free baseline period and subsequently at follow-up visits after randomization. The IIEF EF domain has a 30-point total score, where higher scores reflect better erectile function. SEP is a diary in which patients recorded each sexual attempt made throughout the study.

Drug forms and strengths: 2.5 mg, 5 mg, 10 mg, 20 mg

SEP Question 2 asks, “Were you able to insert your penis into the partner's vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials — The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hispanic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>90%) patients reported ED of at least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices. co-morbid conditions, including diabetes mellitus,

Drug Label Information

CIALIS was taken once daily at doses ranging from 2.5 to 10 mg. Food and alcohol intake were not restricted. Timing of sexual activity was not restricted relative to when patients took Cialis.Results in General ED Population — The primary US efficacy and safety trial included a total of 287 patients, with a mean age of 59 years (range 25 to 82 years). The population was 86% White, 6% Black, 6% Hispanic, and 2% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>96%) patients reported ED of at least 1-year duration.The primary efficacy and safety study conducted outside the US included 268 patients, with a mean age of 56 years (range 21 to 78 years). hypertension, and other cardiovascular disease.

  • The efficacy of Cialis 20mg can vary between individuals.
  • Do not use Cialis to enhance sexual performance beyond its purpose.
  • Excessive doses increase the risk of adverse effects.
  • Always follow your healthcare provider’s instructions.
  • Never share your medication with others.

© 2021 Gastroenterologie im Zentrum, Kasernenstrasse 1, 8180 Bülach, Tel 044 864 19 18, Fax 044 864 19 17